Geode Capital Management, LLC Ptc Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,787,780 shares of PTCT stock, worth $56.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,787,780

Previous 1,663,068 7.5%

Holding current value

$56.5 Million

Previous $48.4 Million 13.01%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$24.69 - $40.12 $3.08 Million - $5 Million	124,712 Added 7.5%	1,787,780 $54.7 Million
Q1 2024 May 13, 2024	BUY	$24.15 - $31.95 $1.25 Million - $1.66 Million	51,843 Added 3.22%	1,663,068 $48.4 Million
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $1.62 Million - $2.63 Million	89,396 Added 5.87%	1,611,225 $44.4 Million
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $1.4 Million - $2.62 Million	62,289 Added 4.27%	1,521,829 $34.1 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $2.99 Million - $4.38 Million	74,130 Added 5.35%	1,459,540 $59.4 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $2.24 Million - $2.87 Million	58,786 Added 4.43%	1,385,410 $67.1 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $1.59 Million - $2.6 Million	47,426 Added 3.71%	1,326,624 $50.6 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $2.27 Million - $2.93 Million	-54,321 Reduced 4.07%	1,279,198 $64.2 Million
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $1.08 Million - $1.92 Million	42,380 Added 3.28%	1,333,519 $53.4 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $633,569 - $847,801	19,009 Added 1.49%	1,291,139 $48.2 Million
Q4 2021 Feb 11, 2022	SELL	$35.36 - $41.86 $229,698 - $271,922	-6,496 Reduced 0.51%	1,272,130 $50.7 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $417,731 - $504,980	11,287 Added 0.89%	1,278,626 $47.6 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $4.49 Million - $5.84 Million	118,239 Added 10.29%	1,267,339 $53.6 Million
Q1 2021 May 12, 2021	BUY	$46.8 - $68.92 $4.91 Million - $7.23 Million	104,952 Added 10.05%	1,149,100 $54.4 Million
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $3.09 Million - $4.36 Million	64,473 Added 6.58%	1,044,148 $63.7 Million
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $837,542 - $1.05 Million	18,444 Added 1.92%	979,675 $45.8 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $1.44 Million - $1.86 Million	33,785 Added 3.64%	961,231 $48.8 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $2.17 Million - $3.98 Million	67,097 Added 7.8%	927,446 $41.4 Million
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $2.35 Million - $3.66 Million	73,080 Added 9.28%	860,349 $41.3 Million
Q3 2019 Nov 12, 2019	BUY	$33.82 - $48.17 $1.79 Million - $2.55 Million	52,852 Added 7.2%	787,269 $26.6 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $1.88 Million - $2.39 Million	53,069 Added 7.79%	734,417 $33 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $3.31 Million - $4.66 Million	117,942 Added 20.93%	681,348 $25.6 Million
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $1.12 Million - $1.75 Million	37,593 Added 7.15%	563,406 $19.3 Million
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $2.69 Million - $3.79 Million	79,294 Added 17.76%	525,813 $24.7 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $2.09 Million - $3.89 Million	81,197 Added 22.23%	446,519 $15.1 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $876,666 - $1.64 Million	50,210 Added 15.93%	365,322 $9.89 Million
Q4 2017 Feb 13, 2018	SELL	$15.14 - $20.89 $725,100 - $1 Million	-47,893 Reduced 13.19%	315,112 $5.26 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $1.2 Million - $1.55 Million	71,590 Added 24.57%	363,005 $7.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	291,415	291,415 $5.34 Million

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.26B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ptc Therapeutics, Inc. Transaction History